Compare2 funds · 1 pair
Picked · 2YTD
FTXHvsARKGVersus · 5Y · 9.0% held in common5–1measures won
Close to theseFee · YTD
Best of the twoNov 3
  • Lowest cost$ a year on $10kFTXH 0.60%
  • Most incometrailing 12-month yieldFTXH 0.66%
  • Best 5 yearsper yearFTXH +12.5%
  • Smallest drop · 1Yworst fall in the past yearFTXH −7.5%
Measures won5–1FTXH wins · of 6 · 5Y
$10,000 · 5Y$18,039FTXH · ARKG $6,586
Lowest cost0.60%FTXH · $60 on $10k
Most income0.66%FTXH · $66 on $10k
Smallest drop−7.5%FTXH · worst fall in 1Y
Held in common9.0%FTXH and ARKG

FTXH vs ARKG

5Y
FTXH
ARKG
First Trust Nasdaq Pharmaceuticals ETF · $1.2BARK Genomic Revolution ETF · $2.2B
+24.1%3 years · per year$19,115 · $22,262+30.6%
+12.5%5 years · per year$18,039 · $6,586−8.0%
0.60%Expense ratio$60 · $75 on $10k · lower wins0.75%
0.66%12-mo yield$66 · $0 on $10k0.00%
−7.5%Worst dropSmaller wins−27.5%
17.7%VolatilityLower wins45.8%
5–1FTXH wins
$10,000 · 5 yearsOne scale
$10k startFTXH $18.0kARKG $6.6kOct 2021Nov 2026
Shared top holdingsFTXH · ARKG
8.2%LLY4.6%
1.8%ILMN4.3%
0.5%GH5.1%
0.5%TXG7.5%
Held in common9.0%
End-of-day Nov 3, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1AFTXHFirst Trust Nasdaq Pharmaceuticals ETFReadDesk0.60%0.66%0.0%+33.8%+46.6%+24.1%+12.5%−7.5%$1.2B
2BARKGARK Genomic Revolution ETFReadDesk0.75%0.00%+2.5%+70.9%+59.0%+30.6%−8.0%−27.5%$2.2B
End-of-day Nov 3, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

FTXH vs ARKG

5Y
First Trust Nasdaq Pharmaceuticals
$18,039
ARK Genomic Revolution
$6,586
$10kNov 2021Nov 2026$18,039$6,586$10kNov 2021Nov 2026$18,039$6,586
MeasureFTXHARKG
Fee0.60%0.75%
Cost on $10k a year$60$75
Yield0.66%0.00%
5 years, per year+12.5%−8.0%
3 years, per year+24.1%+30.6%
Worst drop · 1Y−7.5%−27.5%
Volatility · 1Y17.7%45.8%
5–1measures won
FTXH first
9.0%
holdings shared
Nov 3, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+32.8%
VIGVanguard
+14.0%
Jan 1Nov 3+32.8%+14.0%
+32.8%Year to date+14.0%
3.0%Yield1.5%
$121BAssets$109B
2–0SCHD wins
End-of-day Nov 3, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+7.5%
JEPIJ.P. Morgan
+7.0%
Jan 1Nov 3+7.5%+7.0%
+7.5%Year to date+7.0%
12.3%Yield8.0%
$41.8BAssets$46.0B
2–0JEPQ wins
End-of-day Nov 3, 2026
@TheETFTracker·theetftracker.com

SPYM vs SPY

YTD
SPDRSPYM
+11.5%
SPYSPDR
+11.5%
Jan 1Nov 3+11.5%+11.5%
+11.5%Year to date+11.5%
1.0%Yield1.0%
$185BAssets$798B
0–0level
End-of-day Nov 3, 2026
@TheETFTracker·theetftracker.com

Overlap: FTXH, ARKG

Today
9.0%most shared, FTXH and ARKG
FTXHARKG
FTXH—9.0%
ARKG9.0%—
End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$6most kept, FTXH
FTXH$66 − $60 = $6
ARKG$0 − $75 = −$75
KeptFee
End-of-day Nov 3, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com